How could emerging nanomedicine-based tuberculosis treatments outperform conventional approaches?
作者信息
Kim Jiwon, Enkhtaivan Khongorzul, Yang Jihyuk, Niepa Tagbo H R, Choi Jonghoon
机构信息
School of Integrative Engineering, Chung-Ang University, Seoul, Republic of Korea.
Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA.
出版信息
Nanomedicine (Lond). 2025 Apr;20(7):645-647. doi: 10.1080/17435889.2025.2458447. Epub 2025 Jan 29.
Abstract
摘要
相似文献
1
How could emerging nanomedicine-based tuberculosis treatments outperform conventional approaches?新兴的基于纳米医学的结核病治疗方法如何能比传统方法更有效？
Nanomedicine (Lond). 2025 Apr;20(7):645-647. doi: 10.1080/17435889.2025.2458447. Epub 2025 Jan 29.
2
Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy.纳米医学在结核病治疗中的当前方法及未来前景
Recent Pat Antiinfect Drug Discov. 2017;12(2):120-127. doi: 10.2174/1574891X12666170425122416.
3
A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy.纳米医学在抗结核治疗中的潜力现状展望
Trop Med Infect Dis. 2023 Feb 3;8(2):100. doi: 10.3390/tropicalmed8020100.
4
Advanced drug delivery and therapeutic strategies for tuberculosis treatment.用于结核病治疗的先进药物输送和治疗策略。
J Nanobiotechnology. 2023 Nov 9;21(1):414. doi: 10.1186/s12951-023-02156-y.
5
Nanomedicine: An Emerging Novel Therapeutic Strategy for Hemorrhagic Stroke.纳米医学：一种新兴的出血性脑卒中治疗策略
Int J Nanomedicine. 2022 May 2;17:1927-1950. doi: 10.2147/IJN.S357598. eCollection 2022.
6
Carbon nanomaterials: a new way against tuberculosis.碳纳米材料：对抗结核病的新途径。
Expert Rev Med Devices. 2019 Oct;16(10):863-875. doi: 10.1080/17434440.2019.1671820. Epub 2019 Sep 30.
7
Endotoxin contamination of engineered nanomaterials: Overcoming the hurdles associated with endotoxin testing.工程纳米材料内毒素污染：克服内毒素检测相关障碍。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Nov;13(6):e1738. doi: 10.1002/wnan.1738. Epub 2021 Jul 12.
8
Nanomedicine and experimental tuberculosis: facts, flaws, and future.纳米医学与实验性结核病：事实、缺陷与未来。
Nanomedicine. 2011 Jun;7(3):259-72. doi: 10.1016/j.nano.2011.01.009. Epub 2011 Feb 15.
9
The Macrophage Response to and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy.巨噬细胞对用于结核病治疗的自噬诱导纳米药物的反应及机遇
Front Cell Infect Microbiol. 2021 Feb 8;10:618414. doi: 10.3389/fcimb.2020.618414. eCollection 2020.
10
Ocular Nanomedicine.眼纳米医学。
Adv Sci (Weinh). 2022 May;9(15):e2003699. doi: 10.1002/advs.202003699. Epub 2022 Feb 12.
本文引用的文献
1
Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy.纳米材料通过调控巨噬细胞自噬介导的结核病宿主导向治疗。
J Nanobiotechnology. 2024 Oct 8;22(1):608. doi: 10.1186/s12951-024-02875-w.
2
Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.异烟肼——历史发展、代谢相关毒性及其药理学改进展望
Front Pharmacol. 2024 Sep 19;15:1441147. doi: 10.3389/fphar.2024.1441147. eCollection 2024.
3
Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview.探索耐药结核病的诊断方法：全面综述。
Tuberculosis (Edinb). 2024 Sep;148:102522. doi: 10.1016/j.tube.2024.102522. Epub 2024 May 31.
4
Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles.基于靶向激活巨噬细胞膜包覆纳米颗粒的结核光热治疗。
Nat Nanotechnol. 2024 Jun;19(6):834-845. doi: 10.1038/s41565-024-01618-0. Epub 2024 Feb 21.
5
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.纳米技术在防治感染性和炎症性疾病方面的前沿应用：预防与治疗。
Signal Transduct Target Ther. 2024 Feb 21;9(1):34. doi: 10.1038/s41392-024-01745-z.
6
Application of artificial intelligence in diagnosis of pulmonary tuberculosis.人工智能在肺结核诊断中的应用。
Chin Med J (Engl). 2024 Mar 5;137(5):559-561. doi: 10.1097/CM9.0000000000003018. Epub 2024 Feb 19.
7
Biosensors; nanomaterial-based methods in diagnosing of .生物传感器；基于纳米材料的诊断方法 。（原文句子不完整，翻译可能不太准确，完整准确的翻译需结合完整原文）
J Clin Tuberc Other Mycobact Dis. 2023 Dec 25;34:100412. doi: 10.1016/j.jctube.2023.100412. eCollection 2024 Feb.
8
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.推进纳米技术以改善癌症靶向治疗：克服其临床实施中的障碍。
Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0.
9
Physiological Barriers and Strategies of Lipid-Based Nanoparticles for Nucleic Acid Drug Delivery.基于脂质的核酸药物传递的生理屏障和策略。
Adv Mater. 2024 May;36(22):e2303266. doi: 10.1002/adma.202303266. Epub 2023 Nov 10.
10
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.科学进展与结核病的终结：《柳叶刀》结核病委员会报告
Lancet. 2023 Oct 21;402(10411):1473-1498. doi: 10.1016/S0140-6736(23)01379-X. Epub 2023 Sep 13.
Zotero 插件